DexCom Ebit vs Operating Income Analysis

DXCM Stock

USD 77.83 5.00 6.87%

DexCom financial indicator trend analysis is much more than just examining DexCom Inc latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether DexCom Inc is a good investment. Please check the relationship between DexCom Ebit and its Operating Income accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Ebit vs Operating Income

Ebit vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of DexCom Inc Ebit account and Operating Income. At this time, the significance of the direction appears to have totally related.

The correlation between DexCom's Ebit and Operating Income is 0.99. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Operating Income in the same time period over historical financial statements of DexCom Inc, assuming nothing else is changed. The correlation between historical values of DexCom's Ebit and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of DexCom Inc are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Ebit i.e., DexCom's Ebit and Operating Income go up and down completely randomly.

Correlation Coefficient

0.99

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Ebit

Operating Income

Operating Income is the amount of profit realized from DexCom Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of DexCom Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most indicators from DexCom's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into DexCom Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

At this time, DexCom's Selling General Administrative is very stable compared to the past year. As of the 26th of November 2024, Tax Provision is likely to grow to about 177.3 M, while Issuance Of Capital Stock is likely to drop about 19.7 M.

DexCom fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Total Current Assets	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Common Stock Total Equity	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Common Stock	Property Plant Equipment	Other Liab	Short Term Investments	Short Long Term Debt Total
Total Assets		0.98	0.95	0.7	0.97	0.5	1.0	0.93	0.94	0.99	0.81	0.92	0.98	0.82	0.96	0.81	0.97	0.97	0.68	0.99	0.96	0.81	0.98	0.94	0.98	0.99
Total Stockholder Equity	0.98		0.89	0.75	0.98	0.56	0.98	0.86	0.89	0.97	0.73	0.88	0.95	0.72	0.92	0.72	0.94	0.94	0.76	0.96	0.9	0.72	0.94	0.97	0.97	0.97
Net Debt	0.95	0.89		0.46	0.88	0.35	0.93	0.97	0.94	0.96	0.9	0.87	0.97	0.89	0.97	0.89	0.92	0.97	0.47	0.97	0.98	0.89	0.96	0.86	0.96	0.94
Cash	0.7	0.75	0.46		0.81	0.58	0.75	0.45	0.51	0.62	0.24	0.71	0.57	0.44	0.52	0.31	0.73	0.56	0.86	0.67	0.52	0.31	0.58	0.69	0.64	0.73
Cash And Short Term Investments	0.97	0.98	0.88	0.81		0.55	0.99	0.83	0.85	0.93	0.68	0.91	0.91	0.75	0.88	0.68	0.97	0.91	0.8	0.96	0.87	0.68	0.9	0.94	0.97	0.98
Common Stock Shares Outstanding	0.5	0.56	0.35	0.58	0.55		0.52	0.33	0.42	0.48	0.06	0.55	0.44	0.31	0.38	0.34	0.45	0.44	0.79	0.45	0.38	0.34	0.44	0.49	0.48	0.49
Total Current Assets	1.0	0.98	0.93	0.75	0.99	0.52		0.9	0.91	0.97	0.76	0.93	0.96	0.81	0.94	0.77	0.98	0.95	0.72	0.99	0.94	0.77	0.95	0.94	0.98	1.0
Other Current Liab	0.93	0.86	0.97	0.45	0.83	0.33	0.9		0.95	0.95	0.94	0.81	0.97	0.87	0.98	0.94	0.9	0.96	0.38	0.95	0.99	0.94	0.97	0.85	0.89	0.91
Total Current Liabilities	0.94	0.89	0.94	0.51	0.85	0.42	0.91	0.95		0.97	0.88	0.85	0.98	0.86	0.97	0.93	0.85	0.97	0.5	0.94	0.95	0.93	0.97	0.84	0.9	0.92
Property Plant And Equipment Net	0.99	0.97	0.96	0.62	0.93	0.48	0.97	0.95	0.97		0.85	0.9	1.0	0.81	0.97	0.86	0.93	0.98	0.6	0.98	0.97	0.86	1.0	0.92	0.96	0.97
Retained Earnings	0.81	0.73	0.9	0.24	0.68	0.06	0.76	0.94	0.88	0.85		0.62	0.89	0.77	0.92	0.88	0.76	0.87	0.12	0.84	0.91	0.88	0.88	0.76	0.79	0.78
Accounts Payable	0.92	0.88	0.87	0.71	0.91	0.55	0.93	0.81	0.85	0.9	0.62		0.87	0.81	0.81	0.74	0.92	0.85	0.73	0.92	0.87	0.74	0.88	0.77	0.9	0.94
Non Current Assets Total	0.98	0.95	0.97	0.57	0.91	0.44	0.96	0.97	0.98	1.0	0.89	0.87		0.83	0.99	0.9	0.92	0.98	0.55	0.98	0.98	0.9	1.0	0.91	0.95	0.96
Non Currrent Assets Other	0.82	0.72	0.89	0.44	0.75	0.31	0.81	0.87	0.86	0.81	0.77	0.81	0.83		0.85	0.88	0.82	0.87	0.41	0.87	0.87	0.88	0.81	0.66	0.8	0.85
Other Assets	0.96	0.92	0.97	0.52	0.88	0.38	0.94	0.98	0.97	0.97	0.92	0.81	0.99	0.85		0.89	0.91	0.99	0.49	0.96	0.97	0.89	0.98	0.92	0.94	0.94
Common Stock Total Equity	0.81	0.72	0.89	0.31	0.68	0.34	0.77	0.94	0.93	0.86	0.88	0.74	0.9	0.88	0.89		0.75	0.88	0.27	0.85	0.92	1.0	0.89	0.68	0.76	0.8
Non Current Liabilities Total	0.97	0.94	0.92	0.73	0.97	0.45	0.98	0.9	0.85	0.93	0.76	0.92	0.92	0.82	0.91	0.75		0.91	0.66	0.98	0.93	0.75	0.93	0.91	0.96	0.99
Other Current Assets	0.97	0.94	0.97	0.56	0.91	0.44	0.95	0.96	0.97	0.98	0.87	0.85	0.98	0.87	0.99	0.88	0.91		0.57	0.97	0.96	0.88	0.97	0.92	0.96	0.95
Other Stockholder Equity	0.68	0.76	0.47	0.86	0.8	0.79	0.72	0.38	0.5	0.6	0.12	0.73	0.55	0.41	0.49	0.27	0.66	0.57		0.62	0.46	0.27	0.54	0.68	0.68	0.69
Total Liab	0.99	0.96	0.97	0.67	0.96	0.45	0.99	0.95	0.94	0.98	0.84	0.92	0.98	0.87	0.96	0.85	0.98	0.97	0.62		0.98	0.85	0.98	0.91	0.97	0.99
Property Plant And Equipment Gross	0.96	0.9	0.98	0.52	0.87	0.38	0.94	0.99	0.95	0.97	0.91	0.87	0.98	0.87	0.97	0.92	0.93	0.96	0.46	0.98		0.92	0.99	0.87	0.93	0.95
Common Stock	0.81	0.72	0.89	0.31	0.68	0.34	0.77	0.94	0.93	0.86	0.88	0.74	0.9	0.88	0.89	1.0	0.75	0.88	0.27	0.85	0.92		0.89	0.68	0.76	0.8
Property Plant Equipment	0.98	0.94	0.96	0.58	0.9	0.44	0.95	0.97	0.97	1.0	0.88	0.88	1.0	0.81	0.98	0.89	0.93	0.97	0.54	0.98	0.99	0.89		0.91	0.94	0.96
Other Liab	0.94	0.97	0.86	0.69	0.94	0.49	0.94	0.85	0.84	0.92	0.76	0.77	0.91	0.66	0.92	0.68	0.91	0.92	0.68	0.91	0.87	0.68	0.91		0.94	0.92
Short Term Investments	0.98	0.97	0.96	0.64	0.97	0.48	0.98	0.89	0.9	0.96	0.79	0.9	0.95	0.8	0.94	0.76	0.96	0.96	0.68	0.97	0.93	0.76	0.94	0.94		0.98
Short Long Term Debt Total	0.99	0.97	0.94	0.73	0.98	0.49	1.0	0.91	0.92	0.97	0.78	0.94	0.96	0.85	0.94	0.8	0.99	0.95	0.69	0.99	0.95	0.8	0.96	0.92	0.98

Click cells to compare fundamentals

DexCom Account Relationship Matchups

High Positive Relationship

Total Current Assets	+ 1.0	Total Assets
Short Long Term Debt Total	+ 1.0	Total Current Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant Equipment	+ 1.0	Property Plant And Equipment Net
Property Plant Equipment	+ 1.0	Non Current Assets Total
Common Stock	+ 1.0	Common Stock Total Equity

High Negative Relationship

Not Found

DexCom fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.4B	4.3B	4.9B	5.4B	6.3B	6.6B
Total Stockholder Equity	882.6M	1.8B	2.3B	2.1B	2.1B	2.2B
Net Debt	699.5M	1.0B	769.2M	1.4B	2.0B	2.1B
Cash	446.2M	817.6M	1.1B	642.3M	566.3M	594.6M
Cash And Short Term Investments	1.5B	2.7B	2.7B	2.5B	2.7B	2.9B
Common Stock Shares Outstanding	369.2M	390M	428.8M	427.5M	425.5M	246.4M
Liabilities And Stockholders Equity	2.4B	4.3B	4.9B	5.4B	6.3B	6.6B
Total Current Assets	2.0B	3.4B	3.7B	3.7B	4.4B	4.6B
Other Current Liab	88.5M	400.3M	447.6M	753.4M	1.2B	1.2B
Total Current Liabilities	360.2M	614.1M	720.8M	1.8B	1.6B	1.6B
Property Plant And Equipment Net	392.8M	608.6M	889.9M	1.1B	1.2B	1.2B
Retained Earnings	(695.7M)	(202.1M)	(47.4M)	479.9M	1.0B	1.1B
Accounts Payable	256.4M	163.3M	189.4M	237.9M	276.4M	290.2M
Non Current Assets Total	425.6M	865.7M	1.2B	1.7B	1.8B	1.9B
Non Currrent Assets Other	14.2M	21.4M	(4.5M)	28.1M	36.5M	38.3M
Other Assets	14.2M	237.8M	220.8M	369.3M	424.7M	445.9M
Non Current Liabilities Total	1.2B	1.8B	1.9B	1.4B	2.6B	2.8B
Other Current Assets	30M	107.8M	79.3M	153.7M	154.7M	162.4M
Other Stockholder Equity	1.6B	2.0B	1.9B	1.7B	1.1B	1.1B
Total Liab	1.5B	2.5B	2.6B	3.3B	4.2B	4.4B
Property Plant And Equipment Gross	392.8M	608.6M	801.8M	1.1B	1.7B	1.8B
Accumulated Other Comprehensive Income	2.3M	3.2M	500K	(11.6M)	(16.7M)	(15.9M)
Property Plant Equipment	321.3M	515.3M	889.9M	1.1B	1.3B	1.4B
Other Liab	5.7M	80.9M	90M	68.7M	79.0M	83.0M
Short Term Investments	1.1B	1.9B	1.7B	1.8B	2.2B	2.3B
Short Long Term Debt Total	1.1B	1.8B	1.8B	2.1B	2.6B	2.7B
Long Term Debt	1.1B	1.7B	1.7B	1.2B	2.4B	2.6B
Net Receivables	286.3M	428.5M	516.6M	752.2M	987.5M	1.0B
Inventory	119.8M	234.7M	357.3M	306.7M	559.6M	587.6M
Short Term Debt	13.6M	33M	41M	793.1M	21.1M	20.0M
Current Deferred Revenue	1.7M	2.2M	2.1M	10.1M	18.4M	19.3M
Net Tangible Assets	864M	1.8B	2.2B	2.1B	2.5B	2.6B
Good Will	18.6M	19.3M	26.5M	25.7M	25.2M	14.4M
Retained Earnings Total Equity	(695.7M)	(202.1M)	(47.4M)	479.9M	551.9M	579.5M
Capital Surpluse	1.7B	2.1B	2.5B	2.3B	2.6B	1.5B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:

How To Invest In DexCom

Details

Is DexCom Stock a good investment?

Details

What is DexCom's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.157

Earnings Share

1.65

Revenue Per Share

10.089

Quarterly Revenue Growth

0.02

Return On Assets

0.0606

The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

DexCom Ebit vs Operating Income Analysis

Ebit vs Operating Income

Ebit vs Operating Income Correlation Analysis

Correlation Coefficient

Ebit

Operating Income

DexCom fundamental ratios Correlations

DexCom Account Relationship Matchups

High Positive Relationship

High Negative Relationship

DexCom fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY